| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446688 | European Journal of Cancer | 2012 | 8 Pages |
Abstract
Pegfilgrastim after PBSC transplantation in myeloma and lymphoma is safe, effective when compared with filgrastim and could represent a cost-effective alternative in this setting.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
C. Sebban, A. Lefranc, L. Perrier, P. Moreau, D. Espinouse, A. Schmidt, L. Kammoun, H. Ghesquieres, C. Ferlay, J.O. Bay, S. Lissandre, D. Pérol, M. Michallet, P. Quittet,